Screener
PTC Therapeutics PTCT Increase Decrease In Contingent Consideration
Increase Decrease In Contingent Consideration at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept ptct:IncreaseDecreaseInContingentConsideration.
The source filing: PTC Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001070081-26-000012
FAQ
- What is PTC Therapeutics's increase decrease in contingent consideration?
- PTC Therapeutics (PTCT) reported increase decrease in contingent consideration of -$4.68M in Q1 2025.
- How has PTC Therapeutics's increase decrease in contingent consideration changed year-over-year?
- PTC Therapeutics's increase decrease in contingent consideration decreased by 940.9% year-over-year, from -$450K to -$4.68M.
- What does increase decrease in contingent consideration mean?
- Represents the cash outflow or adjustment related to performance-based payments owed to third parties, typically arising from business acquisitions or licensing deals. Monitoring this metric helps investors understand the timing and magnitude of future obligations triggered by commercial or clinical milestones.
Ask your AI about PTC Therapeutics's increase decrease in contingent consideration.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude